| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/17/2011 | US20110038897 Oral controlled release formulations |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038807 Compositions and methods for treating bipolar disorder |
| 02/17/2011 | US20110038806 Medicaments for inhalation comprising an anticholinergic and a steroid |
| 02/17/2011 | US20110038793 Microsphere comprising an organic lanthanide metal complex |
| 02/17/2011 | CA2771539A1 Pharmaceutical compositions with tetrabenzine |
| 02/17/2011 | CA2771054A1 Novel pharmaceutical formulations against drug misuse |
| 02/17/2011 | CA2771053A1 Floating microgranules |
| 02/17/2011 | CA2771022A1 Photochemical internalization method |
| 02/17/2011 | CA2771021A1 Photosensitizing compositions |
| 02/17/2011 | CA2770583A1 Pharmaceutical composition for relieving pain |
| 02/17/2011 | CA2770582A1 Steroid solvates |
| 02/17/2011 | CA2770578A1 Dry powder inhaler formulations |
| 02/17/2011 | CA2770570A1 Immunomodulatory compositions comprising a polymer matrix and an oil phase |
| 02/17/2011 | CA2770334A1 Orally disintegrating compositions of linaclotide |
| 02/17/2011 | CA2770262A1 Pharmaceutical composition including a dha ester to be parenterally administered |
| 02/17/2011 | CA2769929A1 Ophthalmic drug delivery system containing phospholipid and cholesterol |
| 02/17/2011 | CA2769803A1 Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate |
| 02/17/2011 | CA2769695A1 Pharmaceutical composition and administrations thereof |
| 02/17/2011 | CA2769616A1 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein |
| 02/17/2011 | CA2764236A1 Compositions and methods for treating fungal infection of the nail |
| 02/16/2011 | EP2284189A2 Nucleic acid molecules encoding fibroblast growth factor-like (FGF-like) polypeptides |
| 02/16/2011 | EP2283897A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283896A2 HSA-free formulations of interferon-beta |
| 02/16/2011 | EP2283865A1 Method of increasing testosterone and related steroid concentrations in women |
| 02/16/2011 | EP2283864A1 Liquid dosage compositions fo stable nanoparticulate active agents |
| 02/16/2011 | EP2283858A2 West Nile Vaccine |
| 02/16/2011 | EP2283850A1 Pharmaceutical compositions and methods for peptide treatment |
| 02/16/2011 | EP2283845A1 Sustained release drug delivery system containing codrugs |
| 02/16/2011 | EP2283844A1 A solid pharmaceutical dosage formulation comprising lopinavir |
| 02/16/2011 | EP2283842A1 Tamper-resitant oral opioid agonist formulations |
| 02/16/2011 | EP2283841A1 Selective serotonin receptor inverse agonists as therapeutics for disease |
| 02/16/2011 | EP2283837A2 Docosahexaenoic acid for treating subclinical inflammation |
| 02/16/2011 | EP2283830A1 Aqueous enteric capsule coating |
| 02/16/2011 | EP2283829A1 Controlled release hydrocodone formulations |
| 02/16/2011 | EP2283828A1 Pharmaceutical compositions |
| 02/16/2011 | EP2283827A1 Controlled release preparation |
| 02/16/2011 | EP2283826A2 Galenic formulations of organic compounds |
| 02/16/2011 | EP2283825A1 Enteric solid oral dosage form of a bisphosphonate containing a chelating agent |
| 02/16/2011 | EP2283824A1 Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin |
| 02/16/2011 | EP2283823A1 Effervescent formulations comprising a phosphonate and methods for their preparation |
| 02/16/2011 | EP2283822A2 Spray drying processes for forming solid amorphous dispersions of drugs and polymers |
| 02/16/2011 | EP2283821A1 Preparation of biodegradable microparticles containing a biologically active agent |
| 02/16/2011 | EP2283820A1 Residual solvent extraction method and microparticles produced thereby |
| 02/16/2011 | EP2283819A1 DPP IV inhibitor formulations |
| 02/16/2011 | EP2283818A1 Method of making particles for use in a pharmaceutical composition |
| 02/16/2011 | EP2283817A1 Method of making particles for use in a pharmaceutical composition |
| 02/16/2011 | EP2283816A1 Melt-extruded orally administrable opioid formulations |
| 02/16/2011 | EP2283815A1 Propellant-free non polar buccal spray of a sedative |
| 02/16/2011 | EP2283814A1 Polar buccal spray of a sedative |
| 02/16/2011 | EP2283813A1 Propellant-free polar buccal spray of a sedative |
| 02/16/2011 | EP2283812A2 Topical antiviral formulations |
| 02/16/2011 | EP2283811A1 Solid pharmaceutical composition comprising donepezil hydrochloride |
| 02/16/2011 | EP2283810A1 Orally administered bacteria as vehicles for systemic delivery of agents |
| 02/16/2011 | EP2283809A1 Microneedle array using porous substrate and process for producing same |
| 02/16/2011 | EP2283805A1 Compositions comprising a zinc containing compound dissolved in a hydrophobic phase |
| 02/16/2011 | EP2283802A1 Medicinal preparation for treating inflammatory processes |
| 02/16/2011 | EP2283027A2 Protein formulation |
| 02/16/2011 | EP2282973A2 Ordered mesoporous silica material |
| 02/16/2011 | EP2282777A1 Topical combinations comprising an antimycotic agent and an antiviral agent |
| 02/16/2011 | EP2282727A2 Polymerized micelles |
| 02/16/2011 | EP2282726A1 Delivery system for an active ingredient |
| 02/16/2011 | EP2282725A1 Nasal formulations of insulin |
| 02/16/2011 | EP2282724A2 Modified drugs for use in liposomal nanoparticles |
| 02/16/2011 | EP2282723A2 Endoplasmic reticulum targeting liposomes |
| 02/16/2011 | EP2282722A2 Self-microemulsifying systems incorporated into liquid core microcapsules |
| 02/16/2011 | EP2282721A2 Transnasal anticonvulsive pharmaceutical composition comprising poorly soluble anticonvulsant |
| 02/16/2011 | EP2282720A2 Intracellular antibody delivery |
| 02/16/2011 | EP2282719A2 Compositions and methods for treating multiple sclerosis |
| 02/16/2011 | EP2282718A2 Programmed-release, nanostructured biological construct for stimulating cellular engraftment for tissue regeneration |
| 02/16/2011 | EP2282712A2 Medical microbubble generation |
| 02/16/2011 | EP2282645A2 Flavor impregnation of a chewing gum core |
| 02/16/2011 | EP2282626A1 A device for encapsulating seeds and a method |
| 02/16/2011 | EP2061433B1 Compositions for enhancing transport through mucus |
| 02/16/2011 | EP2038325B1 Polyurethane elastomers |
| 02/16/2011 | EP1940478B1 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 02/16/2011 | EP1781260B9 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/16/2011 | EP1773450B1 Therapeutically combinations |
| 02/16/2011 | EP1708686B1 Generally linear effervescent oral fentanyl dosage form and methods of administering |
| 02/16/2011 | EP1699434B1 Process for preparing a medicament |
| 02/16/2011 | EP1450763B1 Agent for treating excess weight in association with other indications |
| 02/16/2011 | EP1424080B1 Gnrh agonist combination drugs |
| 02/16/2011 | CN201743945U Cold preventing plaster |
| 02/16/2011 | CN1994385B Externally applied Chinese medicinal effervescence tablet for fumigating and washing to treat external piles and anal fissure and method for preparing same |
| 02/16/2011 | CN1994330B Pulverization method for Chinese animal medicine |
| 02/16/2011 | CN1961950B Method for preparing Chinese medicinal soft capsule for stopping cough and resolving phlegm |
| 02/16/2011 | CN1935191B External ointment for treating facioplegia and its production method |
| 02/16/2011 | CN1931251B Analgesic medicine composition and its preparation process and application |
| 02/16/2011 | CN1919247B Chinese medicine for treating cardiovascular and cerebrovascular disease |
| 02/16/2011 | CN1919240B Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases |
| 02/16/2011 | CN1872077B Medicine for treating cardiac insufficiency |
| 02/16/2011 | CN1814217B Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof |
| 02/16/2011 | CN1814194B Chinese-western medicine composition for treating infant's common cold and preparation method thereof |
| 02/16/2011 | CN1814193B Chinese medicine composition for treating nephritis dropsy and preparation method thereof |
| 02/16/2011 | CN1660398B Combination of medication for treating sleep disorder |
| 02/16/2011 | CN101977634A Method for the synthesis of hollow spheres |
| 02/16/2011 | CN101977629A Therapeutic agent for fibroid lung |
| 02/16/2011 | CN101977624A Preparation of a pharmaceutical composition for increasing bone mineral density |
| 02/16/2011 | CN101977615A Inhibitor for blood phosphorus level elevation |
| 02/16/2011 | CN101977610A Methods of treating viral infections |